Compass Therapeutics Ratios (2022-2026) | CMPX

Ratios Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Profitability
EBT Margin (Quarter) -1,538.35%
EBIT Margin (Quarter) -1,770.00%
EBITDA Margin (Quarter) -1,538.47%
Operating Margin (Quarter) -1,770.00%
Net Margin (Quarter) -1,538.35%
FCF Margin (Quarter) -1,265.18%
Efficiency
Assets Average (Quarter) 193.81M183.58M174.61M163.46M159.01M158.38M152.38M144.78M135.93M124.07M173.98M225.42M212.38M
Equity Average (Quarter) 178.45M171.78M164.17M154.29M152.80M151.58M142.25M131.82M117.76M101.74M151.41M203.20M191.63M
Invested Capital (Quarter) 181.64M175.26M168.29M160.04M148.54M157.06M146.10M138.40M125.23M110.28M93.21M209.61M196.79M186.47M
Asset Utilization Ratio (Quarter) 0.010.010.010.01
Leverage & Solvency
Equity Ratio (Quarter) 0.910.930.940.940.950.970.940.930.890.840.800.910.900.91
Valuation
Enterprise Value (Quarter) -186.56M-175.17M-168.75M-163.70M-152.46M-176.06M-146.23M-118.00M-127.29M-113.20M-101.52M-219.90M-209.47M-194.69M
Return Ratios
Return on Sales (Quarter) -0.15%-0.58%-0.62%-0.78%
Return on Capital Employed (Quarter) -32.36%-34.44%-37.04%-37.48%-41.67%-51.08%-61.56%-44.21%-34.45%-37.20%
Return on Assets (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%0.00%0.00%0.00%
Return on Equity (Quarter) 0.00%0.00%0.00%0.00%0.00%0.00%0.00%-0.01%0.00%0.00%0.00%